We are live on ! Find out more
HSTM icon

HealthStream

175 hedge funds and large institutions have $588M invested in HealthStream in 2023 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 66 increasing their positions, 54 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

92% more first-time investments, than exits

New positions opened: 23 | Existing positions closed: 12

22% more repeat investments, than reductions

Existing positions increased: 66 | Existing positions reduced: 54

19% more capital invested

Capital invested by funds: $493M → $588M (+$95.2M)

6% more funds holding

Funds holding: 165175 (+10)

6.01% more ownership

Funds ownership: 64.86%70.87% (+6%)

Holders
175
Holders Change
+10
Holders Change %
+6.06%
% of All Funds
2.79%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
23
Increased
66
Reduced
54
Closed
12
Calls
$5K
Puts
Net Calls
+$5K
Net Calls Change
+$16K

HSTM Hedge Fund Activity: Q1 2023 in Review

175 of the 6,283 institutional investors tracked by Wall St. Rank reported a position in HealthStream (HSTM) for Q1 2023, worth a combined $588M — up 19% from $493M a quarter earlier.

Buyers outnumbered sellers: 23 funds opened new HSTM positions and 12 closed out — a net gain of 11 holders — while 66 added to existing stakes and 54 trimmed.

The largest buyer was Assenagon Asset Management, adding an estimated $4.73M. The largest seller was Brown Brothers Harriman & Co, cutting an estimated $10.3M.

  • 175 institutional investors held HealthStream (HSTM) as of Q1 2023, up from 165 in Q4 2022.
  • Funds reported $588M of HealthStream stock for Q1 2023, up 19% quarter-over-quarter.
  • 23 funds opened new HealthStream positions in Q1 2023 and 12 closed out, a net change of +11 holders.
  • The largest HealthStream buyer in Q1 2023 was Assenagon Asset Management, an estimated $4.73M added.
  • The largest HealthStream seller in Q1 2023 was Brown Brothers Harriman & Co, an estimated $10.3M sold.

Based on aggregated 13F filings for Q1 2023.